Natera

Natera

Yahoo Finance • 6 days ago

When Multi-Cancer Blood Screens Could Finally Take Off

Grail is awaiting an FDA ruling on a cancer screening test, but already more tests are finding their way into medical practices. Continue Reading... Full story

Yahoo Finance • 9 days ago

U.S. Supreme Court Rejects CareDxA’s Appeal in Natera, Inc. (NTRA) False-advertising Dispute

Natera, Inc. (NASDAQ:NTRA) is among the Best Healthcare Stocks. On June 1, Reuters reported that the U.S. Supreme Court declined to hear CareDx's appeal in its false-advertising dispute with Natera, Inc. (NASDAQ:NTRA). It left intact lowe... Full story

Yahoo Finance • 12 days ago

NTRA, Eledon From Partnership For Prospera Use In Phase 3 Kidney Transplant Trial

(RTTNews) - Natera, Inc. (NTRA), a clinical-stage company in cell-free DNA and precision medicine, and Eledon Pharmaceuticals, Inc. (ELDN), a clinical-stage biotechnology company developing immune-modulating therapies, have entered into a... Full story

Yahoo Finance • 13 days ago

US Stock Market Today S&P 500 Futures Edge Higher On Cooler Yields Data

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Thursday, Jun, 25 2026 US stock futures are slightl... Full story

Yahoo Finance • 21 days ago

1 Healthcare Stock for Long-Term Investors and 2 We Turn Down

1 Healthcare Stock for Long-Term Investors and 2 We Turn Down From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persi... Full story

Yahoo Finance • 21 days ago

Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA)

Natera, Inc. (NASDAQ:NTRA) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 5, Goldman Sachs initiated coverage on Natera, Inc. (NASDAQ:NTRA) with a Neutral rating and a $245 price target, noting the firm's leade... Full story

Yahoo Finance • 24 days ago

Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock

We just covered the Top 10 Stock Picks of 10 Famous Billionaires. Natera (NASDAQ:NTRA) ranks #7 (see Top 5 Stock Picks of 5 Famous Billionaires). Number of Hedge Funds: 68 Top Pick Of: Stanley Druckenmiller — Duquesne Family Office Nat... Full story

Yahoo Finance • 29 days ago

HHS indicates skepticism on international cancer risk assessments

[US Department of Health and Human Services] HHS, along with the State Department, on Monday released a statement that indicated the federal government may challenge cancer hazard assessments issued by the International Agency for Researc... Full story

Yahoo Finance • 29 days ago

NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC

Natera NTRA recently announced a collaboration with CytoDyn to evaluate circulating tumor DNA (ctDNA) dynamics and generate real-world molecular data in support of the latter’s metastatic colorectal cancer (mCRC) program. The collaboration... Full story

Yahoo Finance • 29 days ago

Billionaire Stanley Druckenmiller Likes This Cancer Stock

We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Natera, Inc. (NASDAQ:NTRA) ranks #1 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Natera (NASDAQ:NTRA) d... Full story

Yahoo Finance • last month

Natera And 2 Other Companies That May Be Trading Below Their Estimated Value

The United States market has experienced a notable upswing, climbing 1.6% in the last week and rising 28% over the past year, with earnings expected to grow by 17% annually. In such an environment, identifying stocks that may be trading be... Full story

Yahoo Finance • last month

NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million

On May 15, 2026, NWI Management LP reported selling all 42,700 shares of MercadoLibre(NASDAQ:MELI). What happened According to an SEC filing dated May 15, 2026, NWI Management LP sold all 42,700 shares of MercadoLibre during the first qu... Full story

Yahoo Finance • 2 months ago

5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call

Natera’s first quarter was marked by robust top-line growth and higher-than-expected sales volumes, but the market responded negatively due to a wider-than-anticipated GAAP loss. Management attributed the revenue momentum primarily to stro... Full story

Yahoo Finance • 2 months ago

Natera Inc. (NTRA): Billionaire Tom Steyer’s Stock Pick with Huge Upside Potential

We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Natera, Inc. (NASDAQ:NTRA) ranks 3rd on this list. Natera, Inc. (NASDAQ:NTRA) has been a staple in the 13F portfolio of Farallon Capital since the seco... Full story

Yahoo Finance • 2 months ago

William Blair Initiates Natera (NTRA) With Outperform

Natera, Inc. (NASDAQ:NTRA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like.William Blair Initiates Natera (NTRA) With Outperform William Blair initiated coverage of Natera, Inc. (NASDAQ:NTRA) with an Outperform rat... Full story

Yahoo Finance • 2 months ago

Should You Be Bullish on Natera (NTRA)?

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the Fund) declined 6.97% (Institutional Sha... Full story

Yahoo Finance • 3 months ago

3 Reasons We’re Fans of Natera (NTRA)

Natera has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6%. The stock now trades at $208.20, marking a 10.5% gain. This was partly thanks to its solid quarterly results, and the performance may ha... Full story

Yahoo Finance • 3 months ago

3 Reasons NTRA Has Explosive Upside Potential

Even during a down period for the markets, Natera has gone against the grain, climbing to $211.23. Its shares have yielded a 22.1% return over the last six months, beating the S&P 500 by 23.8%. This was partly due to its solid quarterly re... Full story

Yahoo Finance • 3 months ago

Natera awarded 30% ongoing royalty in MRD patent litigation

Natera (NTRA [https://seekingalpha.com/symbol/NTRA]) on Thursday said the United States District Court for the District of Delaware has ordered an ongoing 30% royalty on certain post-injunction sales tied to its long-running patent dispute... Full story

Yahoo Finance • 3 months ago

Stanley Druckenmiller Loaded Up on This Stock That’s Down 77%

Quick Read Sea (SE) surged 244.3% in Druckenmiller’s portfolio to 944k shares worth $120M, now constituting 2.85% of his holdings, as the company trades at just 10x free cash flow despite 17.2% three-year revenue growth and 10x profit exp... Full story